Hemoglobin-Based Oxygen Carrier (HBOC) Development in Trauma: Previous Regulatory Challenges, Lessons Learned, and a Path Forward
Autor: | Peter E, Keipert |
---|---|
Rok vydání: | 2017 |
Předmět: | |
Zdroj: | Advances in experimental medicine and biology. 977 |
ISSN: | 0065-2598 |
Popis: | Historically, hemoglobin-based oxygen carriers (HBOCs) were being developed as "blood substitutes," despite their transient circulatory half-life (~ 24 h) vs. transfused red blood cells (RBCs). More recently, HBOC commercial development focused on "oxygen therapeutic" indications to provide a temporary oxygenation bridge until medical or surgical interventions (including RBC transfusion, if required) can be initiated. This included the early trauma trials with HemAssist |
Databáze: | OpenAIRE |
Externí odkaz: |